Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Summary

Andrew Huberman explora la intersección entre el cuidado personal, la medicina moderna y el auge de los fármacos. Analiza cómo la pandemia cambió la percepción del bienestar, impulsando una mayor soberanía en la salud personal. Se sumerge en el uso de péptidos (como GLP-1 para el control de peso y BPC-157 para recuperación) y tecnologías emergentes para el sueño y la cognición, subrayando la importancia de la ciencia mecanística sobre las modas. Finalmente, reflexiona sobre la optimización humana mediante herramientas biológicas y el futuro de la comunicación entre especies a través de la inteligencia artificial.

Topics covered

• Evolución del cuidado personal
• Regulación biológica y sueño

+4 more topics (full content when you follow the channel)

Transcript excerpt

You don't want to stimulate the sympathetic nervous system so much for so often. It can probably shorten your life. There's a whole category of what are called growth hormone secretagogues, which are very popular. When people hear erection, fat loss, energy, tan, they're like, "Oh, great." This isn't the kind of thing you do to like go on vacation. You got to be real careful with these things. >> Nearly one in seven Americans is taking a GLP-1 drug. 20% have tried them. What do you think the future looks like? >> In theory, you could eradicate obesity. People can lose up to a third of their body weight. Melanotan, which makes people tan from the inside, raises energy and libido dramatically, fat loss dramatically. BPC-157, body protection compound. It's not legal, but it's not necessarily enforced. They list them as for research purposes only, not for human use. I mean, who's doing resea…